Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030552 (
paresis
)
5,831
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The paper presents the results of clinical and neurophysiologic study of muscular tonus in 94 patients aged 42-70 years in early recovery after ischemic stroke. Selective role of spasticity was estimated in clinical pattern of motor disorders in groups of the patients with different disorders of muscular tonus with the same degree of
paresis
. Efficiency of antispastic preparation sirdalud was analyzed in 28 patients from this group.
Sirdalud
in daily dose of 6-12 mg in patients with prevalence of a spasticity in a clinical picture of the
paresis
and with either moderate or manifested degree of
paresis
of the extremities has significant antispastic effect without any decrease of muscular strength, which, in turn, increases the degree of restoration of motor functions.
...
PMID:[Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke]. 981 84
